A “Capture-and-Lock” Ozone-Reservoir Hydrogel for Rheumatoid Arthritis Therapy
Biomacromolecules · 09.11.2026 · 27 (11) · 7121-7133
DOI: 10.1021/acs.biomac.6c00978 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomacromolecules, online erschienen am 07.10.2026. Verfasst von Xiangjing Kong und 6 weiteren Autor:innen. Beteiligte Einrichtung: Qingdao Medical College, Qingdao University, Qingdao266073, China. Hauptthemen laut MEDLINE: Arthritis, Rheumatoid, Ozone, Hydrogels, Arthritis, Experimental. Die Arbeit nennt 54 Literaturangaben. Gefördert von: National Key Research and Development Project of China, Shandong Provincial Natural Science Fundation, Shandong Postdoctoral Science Foundation.
Abstract (Originalsprache)
Rheumatoid arthritis (RA) is a chronic autoimmune disease driven by excessive reactive oxygen species (ROS) and M1 polarization, leading to synovial inflammation and bone destruction. Current immunosuppressants cannot target these core mechanisms and cause severe side effects. Ozone shows potential for RA treatment via anti-oxidant and anti-inflammatory effects, but its instability, rapid diffusion, and short retention severely limit clinical efficacy. Herein, we develop an injectable ozone-reservoir hydrogel (O3@F@OHC) by covalently incorporating perfluorinated polymer (PFAM) into a Schiff-base crosslinked network of oxidized hyaluronic acid and carboxymethyl chitosan. The hydrogel achieves stable ozone loading and sustained release for over 48 h through a “capture-and-lock” mechanism, with PFAM acting as an efficient “ozone sponge”. This hydrogel also exhibits favorable self-healing, biocompatibility, and adaptive biodegradability. In vitro, ozone released from O3@F@OHC hydrogel could activate endogenous antioxidant defense system, thereby enhances cellular antioxidant capacity, eliminates excessive intracellular free radicals, downregulates inducible nitric oxide synthase (iNOS) expression, and ultimately exerts anti-inflammatory effects. In rats with collagen-induced arthritis, this hydrogel alleviates synovial inflammation and bone destruction. This work provides a promising strategy for ozone-based intra-articular therapy of RA.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Qingdao Medical College, Qingdao University, Qingdao266073, China.
- Shandong Key Laboratory of Neurorehabilitation, Shandong Engineering Research Center for Tissue Rehabilitation Materials and Devices, Qingdao Key Laboratory of Smart Rehabilitation Material, School of Rehabilitation Sci…
- Department of Anesthesia and Perioperative Medicine, Qingdao Central Hospital, University of Health and Rehabilitation Sciences, Qingdao266042, China.
- College of Chemistry and Chemical Engineering, Ocean University of China, 266100Qingdao, P. R. China.
ORCID-Profile: Qihui Zhou
Förderung
- National Key Research and Development Project of China
- Shandong Provincial Natural Science Fundation
- Shandong Postdoctoral Science Foundation
- Qingdao Science and Technology Benefiting the People Demonstration Project
- Qingdao Future Industry Cultivation Special Project-Emerging Industry Cultivation Plan (Biomedicine and Medical Device Field)
- Qingdao Key Technology Research and Industrialization Demonstration Project
- China Postdoctoral Science Foundation
- Special Program for Enhancing Clinical Research Capabilities of UHRS
Zitieren
APA
Kong, X., Cao, X., Cao, Q., Han, T., Li, G., Zhou, Q., & Wang, S. (2026). A “Capture-and-Lock” Ozone-Reservoir Hydrogel for Rheumatoid Arthritis Therapy. Biomacromolecules, 27(11), 7121-7133. https://doi.org/10.1021/acs.biomac.6c00978
Vancouver
Kong X, Cao X, Cao Q, Han T, Li G, Zhou Q, et al. A “Capture-and-Lock” Ozone-Reservoir Hydrogel for Rheumatoid Arthritis Therapy. Biomacromolecules. 2026;27(11):7121-7133. doi:10.1021/acs.biomac.6c00978
BibTeX
@article{Kong2026,
author = {Kong, Xiangjing and Cao, Xianghui and Cao, Qianqian and Han, Tongfeng and Li, Guotai and Zhou, Qihui and Wang, Shoushi},
title = {A “Capture-and-Lock” Ozone-Reservoir Hydrogel for Rheumatoid Arthritis Therapy},
journal = {Biomacromolecules},
year = {2026},
volume = {27},
number = {11},
pages = {7121--7133},
doi = {10.1021/acs.biomac.6c00978}
}
EUVIMED